| Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB-Mutated Cluster I Pheochromocytoma and Paraganglioma Y Pang, Y Lu, V Caisova, Y Liu, P Bullova, TT Huynh, Y Zhou, D Yu, ... Clinical Cancer Research 24 (14), 3423-3432, 2018 | 69 | 2018 |
| Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints A Bezawork-Geleta, H Wen, LF Dong, B Yan, J Vider, S Boukalova, ... Nature communications 9 (1), 2221, 2018 | 51 | 2018 |
| The use of anchored agonists of phagocytic receptors for cancer immunotherapy: B16-F10 murine melanoma model T Janotová, M Jalovecká, M Auerová, I Švecová, P Bruzlová, V Maierová, ... PloS one 9 (1), e85222, 2014 | 37 | 2014 |
| Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid Y Liu, Y Pang, B Zhu, O Uher, V Caisova, TT Huynh, D Taieb, ... Clinical Cancer Research 26 (14), 3868-3880, 2020 | 34 | 2020 |
| Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors S Rivero-Hinojosa, M Grant, A Panigrahi, H Zhang, V Caisova, ... Nature communications 12 (1), 6689, 2021 | 32 | 2021 |
| Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway Y Pang, C Yang, J Schovanek, H Wang, P Bullova, V Caisova, G Gupta, ... Oncotarget 8 (14), 22313, 2017 | 32 | 2017 |
| Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis V Caisová, O Uher, P Nedbalová, I Jochmanová, K Kvardová, ... International Immunopharmacology 59, 86-96, 2018 | 31 | 2018 |
| Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma Y Liu, Y Pang, V Caisova, J Ding, D Yu, Y Zhou, TT Huynh, H Ghayee, ... Cancers 12 (2), 280, 2020 | 30 | 2020 |
| Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model V Caisová, A Vieru, Z Kumžáková, S Glaserová, H Husníková, N Vácová, ... BMC cancer 16, 1-11, 2016 | 30 | 2016 |
| The significant reduction or complete eradication of subcutaneous and metastatic lesions in a pheochromocytoma mouse model after immunotherapy using mannan-BAM, TLR ligands … V Caisova, L Li, G Gupta, I Jochmanova, A Jha, O Uher, TT Huynh, ... Cancers 11 (5), 654, 2019 | 28 | 2019 |
| The use of Zymosan A and bacteria anchored to tumor cells for effective cancer immunotherapy: B16-F10 murine melanoma model E Waldmannová, V Caisová, J Fáberová, P Sváčková, M Kovářová, ... International immunopharmacology 39, 295-306, 2016 | 27 | 2016 |
| Coley's immunotherapy revived: innate immunity as a link in priming cancer cells for an attack by adaptive immunity O Uher, V Caisova, P Hansen, J Kopecky, J Chmelar, Z Zhuang, J Zenka, ... Seminars in oncology 46 (4-5), 385-392, 2019 | 17 | 2019 |
| Induction of Immune Response against Metastatic Tumors via Vaccination of Mannan‐BAM, TLR Ligands, and Anti‐CD40 Antibody (MBTA) R Medina, H Wang, V Caisová, J Cui, IH Indig, O Uher, J Ye, A Nwankwo, ... Advanced therapeutics 3 (9), 2000044, 2020 | 13 | 2020 |
| Identification of immune cell infiltration in murine pheochromocytoma during combined mannan-BAM, TLR ligand, and anti-CD40 antibody-based immunotherapy O Uher, TT Huynh, B Zhu, LA Horn, V Caisova, K Hadrava Vanova, ... Cancers 13 (16), 3942, 2021 | 6 | 2021 |
| Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations O Uher, V Caisova, L Padoukova, K Kvardova, K Masakova, R Lencova, ... Cancer Immunology, Immunotherapy 70, 3303-3312, 2021 | 5 | 2021 |
| Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints. Nat. Commun. 9, 2221 A Bezawork-Geleta, H Wen, L Dong, B Yan, J Vider, S Boukalova, ... Molecular Therapy: Nucleic Acids, 2018 | 5 | 2018 |
| Použití agonistů FPR receptorů pro terapii nádorových onemocnění V Caisová Jihočeská univerzita, 2014 | 4 | 2014 |
| The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma A Frejlachova, R Lencova, A Venhauerova, M Skalickova, O Uher, ... International Immunopharmacology 118, 110150, 2023 | 2 | 2023 |
| Immu-23. Targeting Metastatic And CNS Tumors Via Mannan-Bam, TLR Ligands and Anti-Cd40 Antibody H Wang, R Medina, V Caisova, O Uher, J Zenka, K Pacak, Z Zhuang Neuro-oncology 21 (Suppl 6), vi123, 2019 | 1 | 2019 |
| The study of cancer immunotherapy based on installation of phagocytosis stimulating ligands on the tumor cells surface and investigation of underlying mechanisms V Caisová Disertační práce. Jihočeská univerzita v Českých Budějovicích, 2017 | 1 | 2017 |
Ondrej UherNational Institutes of Health, NICHDDirección de correo verificada de nih.gov
